The proinflammatory cytokine IL-17 causes Rho-kinase-mediated endothelial dysfunction [23,24], at least in part by NADPH oxidase activation [45] and nrf2 inhibition [46]. The gene discussed is FMO5; the disease is endothelial dysfunction.